Eric C. Salzman
Currently, Eric C. Salzman is Executive Chairman of Merisel, Inc. He is also Chief Restructuring Officer of Safeguard Scientifics, Inc. and on the board of 5 other companies.
He previously held the position of Chairman for SynCardia Systems LLC, Managing Member at SarniHaan Capital Partners LLC, MD-Global Trading Strategies Division at Lehman Brothers Holdings, Inc., MD-Global Trading Strategies Division at Lehman Brothers, Inc. and Mergers & Acquisitions Analyst at Credit Suisse First Boston Corp.
He received an undergraduate degree from the University of Michigan and an MBA from Harvard Business School.
|08/10/2020||11,146||Award at $0 per share.||0|
|08/07/2019||8,028||Derivative/Non-derivative trans. at $0 per share.||0|
|08/01/2019||7,424||Award at $0 per share.||0|
|10/21/2018||8,328||Derivative/Non-derivative trans. at $0 per share.||0|
|08/10/2018||13,409||Derivative/Non-derivative trans. at $22.4 per share.||300,361|
|09/20/2017||11,832||Derivative/Non-derivative trans. at $13.65 per share.||161,506|
|02/09/2017||9,700||Disposition at $15.64 per share.||151,708|
|02/09/2017||300||Disposition at $15.7 per share.||4,710|
|02/08/2017||15,000||Disposition at $15.26 per share.||228,900|
|07/22/2016||21,472||Derivative/Non-derivative trans. at $15.02 per share.||322,509|
|10/21/2015||8,328||Derivative/Non-derivative trans. at $9.67 per share.||80,531|